The intravenous administration of a formulation of interleukin-12 that binds to collagen in established ‘immunologically cold’ murine tumours enhances interferon-γ production by T cells and causes tumour remission, especially when in combination with immune checkpoint blockade therapy.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting collagen to optimize cancer immunotherapy
Experimental Hematology & Oncology Open Access 29 July 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Topalian, S. L., Drake, C. G. & Pardoll, D. M. Cancer Cell 27, 450–461 (2015).
Wherry, E. Nat. Immunol. 12, 492–499 (2011).
Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. Nature 362, 758–761 (1993).
Galon, J. & Bruni, D. Immunity 52, 55–81 (2020).
Bonaventura, P. et al. Front. Immunol. 10, 168 (2019).
Lasek, W., Zagozdzon, R. & Jakobisiak, M. Cancer Immunol. Immunother. 63, 419–435 (2014).
Kobayashi, M. et al. J. Exp. Med. 170, 827–845 (1989).
Stern, A. S. et al. Proc. Natl Acad. Sci. USA 87, 6808–6812 (1990).
Otani, T. et al. Cell. Immunol. 198, 111–119 (1999).
Leonard, J. et al. Blood 90, 2541–2548 (1997).
Mansurov, A. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0549-2 (2020).
Momin, N. et al. Sci. Transl. Med. 11, eaaw2614 (2019).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Scheller, J., Lang, P.A. Collagen-binding IL-12 inflames ‘cold’ tumours. Nat Biomed Eng 4, 483–484 (2020). https://doi.org/10.1038/s41551-020-0560-7
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41551-020-0560-7
This article is cited by
-
Targeting collagen to optimize cancer immunotherapy
Experimental Hematology & Oncology (2025)